TMC Life Sciences Bhd (XKLS:0101) ROCE %: 1.81% (As of Mar. 2026)


XKLS:0101 TMC Life Sciences Bhd XKLS:0101
62 GF Score
Price RM0.45
GF Value RM0.62
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is TMC Life Sciences Bhd ROCE %?

TMC Life Sciences Bhd XKLS:0101 62 ROCE % is 1.81% as of Mar. 2026. GuruFocus rates XKLS:0101 with a GF Score™ of 62/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TMC Life Sciences Bhd's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.81%.

TMC Life Sciences Bhd  (XKLS:0101) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TMC Life Sciences Bhd ROCE % Related Terms

TMC Life Sciences Bhd ROCE % Historical Data

* Premium members only.

The historical data trend for TMC Life Sciences Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMC Life Sciences Bhd ROCE % Chart

TMC Life Sciences Bhd Annual Data
Trend May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.18 3.38 4.74 5.80 1.55

TMC Life Sciences Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 2.06 3.38 4.45 1.81
XKLS:0101
62GF Score
TMC Life Sciences Bhd XKLS:0101
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMC Life Sciences Bhd ROCE % Calculation

TMC Life Sciences Bhd's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=16.408/( ( (1189.723 - 98.62) + (1132.19 - 110.312) )/ 2 )
=16.408/( (1091.103+1021.878)/ 2 )
=16.408/1056.4905
=1.55 %

TMC Life Sciences Bhd's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=18.22/( ( (1119.148 - 107.828) + (1110.002 - 107.114) )/ 2 )
=18.22/( ( 1011.32 + 1002.888 )/ 2 )
=18.22/1007.104
=1.81 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.81% mean?
TMC Life Sciences Bhd (XKLS:0101) has a ROCE % of 1.81% as of Mar. 2026.
Is TMC Life Sciences Bhd's ROCE % too high?
TMC Life Sciences Bhd's current ROCE % is 1.81%. The Healthcare Providers & Services industry median ROCE % is 6.41. TMC Life Sciences Bhd's value of 1.81% is 71.8% below this industry median. Overall, TMC Life Sciences Bhd has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's ROCE % compare to HCA and THC?
TMC Life Sciences Bhd's ROCE % of 1.81% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. TMC Life Sciences Bhd's value of 1.81% is 71.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current ROCE % of 1.81% is 71.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current ROCE % is 1.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.45 — trading 27.4% below its estimated fair value. The current ROCE % is 1.81% and 71.8% below the Healthcare Providers & Services industry median of 6.41. TMC Life Sciences Bhd's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current ROCE % is 1.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?

Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued. The current stock price of RM0.45 is trading 27.4% below its estimated GF Value™ of RM0.62. GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0101:

  • ROCE %: 1.81%
  • GF Value™: RM0.62 vs. price of RM0.45 (27.4% below fair value)
  • GF Score™: 62/100 with 3 warning signs
  • Industry Position: 71.8% below the Healthcare Providers & Services median

No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TMC Life Sciences Bhd Business Description

Address No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
62GF Score

Get the complete analysis for XKLS:0101

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.45
Price
RM0.62
GF Value